Physician
Reliant Immediate Care Medical Group, INC.
Reliant Immediate Care Medical Group, INC. was paid $4.02M by Medicaid between Jan 2018 and Sep 2023, across 57 billing codes. Its largest line is S9083, Global fee urgent care centers — 28% of everything it billed.
33Billing provider infoRELIANT IMMEDIATE CARE MEDICAL GROUP, INC.
LOS ANGELES, CA 90045
LOS ANGELES, CA 90045
33aNPI1801838198assigned 06/12/2006
33bProvider typeEmergency Medicine Physician
28Total paid$4.02M
24GClaims113,769
24DCodes billed57
24AFirst – last monthJan 2018 – Sep 2023
Compared with peers
Next to other Emergency Medicine Physician providers in California
Rank by total paid#126 of 988
Median peer was paid$32K
This provider vs. median127×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,836 | $475K | |
| 2019 | 23,758 | $1.01M | |
| 2020 | 21,015 | $810K | |
| 2021 | 18,187 | $591K | |
| 2022 | 21,582 | $645K | |
| 2023 | 14,391 | $488K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S9083 | Global fee urgent care centers | 28% | 18,221 | 17,127 | $1.11M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 24% | 18,574 | 18,379 | $949K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 15,956 | 15,273 | $642K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 15,786 | 15,076 | $622K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 13% | 10,514 | 10,424 | $515K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 2,463 | 2,394 | $57K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,838 | 4,621 | $27K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,274 | 2,739 | $15K |
| 81003 | <1% | 4,280 | 4,117 | $13K | |
| 81025 | <1% | 2,767 | 2,725 | $12K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,530 | 3,489 | $11K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,576 | 1,540 | $7K |
45 more codes
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 806 | $6K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,161 | $5K |
| 81002 | <1% | 946 | $4K | |
| A4320 | Irrigation tray with bulb or piston syringe, any purpose | <1% | 1,020 | $3K |
| A9150 | Non-prescription drugs | <1% | 839 | $3K |
| 93000 | <1% | 281 | $2K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 264 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 387 | $1K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 154 | $1K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 297 | $1K |
| 73610 | <1% | 188 | $1K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 292 | $1K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 67 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 606 | $992.83 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 262 | $969.23 |
| 90714 | <1% | 198 | $937.21 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 16 | $892.79 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 160 | $878.82 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 264 | $851.23 |
| A6448 | Light compression bandage, elastic, knitted/woven, width less than three inches, per yard | <1% | 187 | $586.50 |
| 73630 | <1% | 94 | $444.18 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 241 | $399.65 |
| 73600 | <1% | 45 | $376.08 | |
| 73564 | <1% | 41 | $344.28 | |
| 82962 | <1% | 84 | $339.14 | |
| 69209 | <1% | 115 | $305.33 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 145 | $300.22 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 100 | $281.16 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 108 | $213.78 |
| A9273 | Cold or hot fluid bottle, ice cap or collar, heat and/or cold wrap, any type | <1% | 49 | $173.00 |
| 86803 | <1% | 82 | $156.49 | |
| 73130 | <1% | 38 | $150.28 | |
| 87273 | <1% | 103 | $130.40 | |
| 73120 | <1% | 26 | $112.30 | |
| 73620 | <1% | 12 | $112.30 | |
| 86592 | <1% | 101 | $92.72 | |
| 86308 | <1% | 12 | $70.00 | |
| A4550 | Surgical trays | <1% | 24 | $70.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 12 | $51.31 |
| 87340 | <1% | 62 | $45.42 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 14 | $32.88 |
| A6220 | Gauze, non-impregnated, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing | <1% | 12 | $8.28 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 12 | $5.83 |
| 85048 | <1% | 38 | $2.28 | |
| 73140 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEBOW, MAX (OWNER)